English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Lilly reports strong second quarter as Foundayo launch lags behind Novo's rival pill
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

New website launched to track vaccine preventable diseases across the United States
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Aurora Therapeutics ends lead gene editing program and reduces workforce
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Gilead focuses on inflammation and cancer as it seeks to diversify beyond HIV
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Study identifies protein that increases lung metastasis risk in cancer patients
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Novo Nordisk CEO emphasizes innovation after pipeline setbacks and earnings report
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Study finds PBS coverage limits widen disparities in pregnancy nausea treatment in Australia
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes